Abstract:Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, has long been thought to exert its benefits by reducing cholesterol synthesis, and has been shown to significantly reduce cardiovascular events and mortality in patients with or without coronary artery disease. However, it is still unknown whether acute administration of simvastatin beneficially affects the cardiac function prior or during ischemia–reperfusion. The aim of this study is to evaluate the cardioprotective effect of acute simvastatin treatment on isolated rat hearts or isolated ischemia–reperfusion hearts. Hearts were isolated from male Sprague–Dawley rats and attached to a Langendorff apparatus. The isolated hearts with or without ischemia (15 min) and reperfusion (60 min) were perfused with different concentrations of simvastatin. The parameters of cardiac function (such as left ventricular developed pressure [LVDP], +d p /d t max, and −d p /d t max), heart rate, and coronary flow were recorded. Simvastatin (3–30 µmol/l) significantly increased LVDP, +d p /d t max, and −d p /d t max in isolated rat hearts perfused for 60 min. Heart rate was depressed by 30 µmol/l simvastatin and the coronary flow was increased by 10 and 30 µmol/l simvastatin. At a concentration of 100 µmol/l simvastatin, worsening of heart function and subsequent cardiac arrest occurred. Administration of simvastatin (3–30 µmol/l) significantly preserved cardiac function detected by LVDP, +d p /d t max, and −d p /d t max in the isolated ischemia/reperfused (15/60 min) rat hearts. Simvastatin also significantly decreased heart rate at 30 µmol/l, and increased coronary flow at 10 and 30 µmol/l in these rat hearts. However, the protective effect of simvastatin reverted to increased damage at 100 µmol/l. Only 3 µmol/l simvastatin pretreatment before 15/60 min ischemia–reperfusion altered LVDP, +d p /d t max, and −d p /d t max. Both heart rate and coronary flow were unaltered after simvastatin pretreatment. Since simvastatin at a concentration lower than 100 µmol/l exerted beneficial effects on cardiac function in isolated perfused rat hearts, it could be applied just after myocardial ischemia and reperfusion.

Simvastatin Inhibits the Formation of NETs by the Mac-1 Pathway to Reduce Hepatic Ischemia-Reperfusion Injury under High-Fat Conditions

Simvastatin Ameliorates Total Liver Ischemia/reperfusion Injury Via KLF2-mediated Mechanism in Rats.

Effects of simvastatin on cardiohemodynamic responses to ischemia–reperfusion in isolated rat hearts

Simvastatin Attenuates Renal Ischemia/reperfusion Injury from Oxidative Stress Via Targeting Nrf2/HO-1 Pathway.

Endothelial Klf2-Foxp1-TGF signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling

Simvastatin Protects the Heart Against Ischemia Reperfusion Injury Via Inhibiting HMGB1 Expression Through PI3K/Akt Signal Pathways

The effects of simvastatin-loaded nanoliposomes on human multilineage liver fibrosis microtissue

Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments

Experimental Study on the Effects of Pretreatment with Simvastatin on Ischemia Reperfusion Induced Myocardial Injury in Rats

Simvastatin Upregulates Lipoxin A4 and Accelerates Neuroinflammation Resolution after Intracerebral Hemorrhage

The Effect of Simvastatin on Gut Microbiota and Lipid Metabolism in Hyperlipidemic Rats Induced by a High-Fat Diet

Simvastatin increases circulating endothelial progenitor cells and inhibits the formation of intracranial aneurysms in rats with diet-induced hyperhomocysteinemia

Simvastatin Ameliorates Renal Lipidosis Through The Suppression Of Renal Cxcl16 Expression In Mice With Adriamycin-Induced Nephropathy

Simvastatin Attenuates Cardiac Isograft Ischemia-Reperfusion Injury by Down-Regulating CC Chemokine Receptor-2 Expression

Protection by Simvastatin on Hyperglycemia-Induced Endothelial Dysfunction Through Inhibiting NLRP3 Inflammasomes

Pretreatment with simvastatin reduces lung injury related to intestinal ischemia-reperfusion in rats

Simvastatin decreases hyperbaric oxygen-induced acute lung injury by upregulating eNOS

Simvastatin Reduces Neutrophils Infiltration Into Brain Parenchyma After Intracerebral Hemorrhage via Regulating Peripheral Neutrophils Apoptosis.

Simvastatin Attenuates Oxidative Stress, NF-κB Activation, and Artery Calcification in LDLR-/- Mice Fed with High Fat Diet via Down-regulation of Tumor Necrosis Factor-α and TNF Receptor 1

HMG-CoA reductase inhibition prior reperfusion improves reparative fibrosis post-myocardial infarction in a preclinical experimental model

Proteomics of Ischemia and Reperfusion Myocardial Mitochondria by Administration of Simvastatin